Latest Peer-Reviewed Article


    Cancers (Basel). 2019 Sep 27;11(10).
    STAT3 and STAT5 Targeting for Simultaneous Management of Melanoma and Autoimmune Diseases.
    Logotheti S, Pützer BM.

Latest Book-Article


    Methods Mol Biol. 2019;1912:33-52. doi: 10.1007/978-1-4939-8982-9_2.
    p73-Governed miRNA Networks: Translating Bioinformatics Approaches to Therapeutic Solutions for Cancer Metastasis.
    Logotheti S, Marquardt S, Pützer BM.

Latest Abstract


    New Horizons in Translational Medicine Volume 4;1-4:48-98.
    E2F1 signaling promotes chemoresistance and lymphogenic metastasis in penile cancer revealing new prognostic biomarkers.
    Fenner F, Goody D, Protzel C, Erbersdobler A, Richter C, Hartz J, Naumann CM, Kalthoff H, Herchenröder O, Hakenberg OW, Pützer BM.

Latest Thesis


    Juliane Marie Hartz (Ärztin)
    Analyse metastasierungsrelevanter microRNAs und deren prognostische Bedeutung für das Peniskarzinom
    Rostock 

... more Publications


    J Exp Clin Cancer Res. 2019 Jul 8;38(1):292. doi: 10.1186/s13046-019-1286-9.
    Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.
    Richter C, Marquardt S, Li F, Spitschak A, Murr N, Edelhäuser BAH, Iliakis G, Pützer BM, Logotheti S.
    Transl Res. 2016 Jul;173:58-73.e2.
    N-bromotaurine surrogates for loss of antiproliferative response and enhances cisplatin efficacy in cancer cells with impaired glucocorticoid receptor.
    Logotheti S, Khoury N, Vlahopoulos SA, Skourti E, Papaevangeliou D, Liloglou T, Gorgoulis V, Budunova I, Kyriakopoulos AM, Zoumpourlis V.
    J Pathol. 2014 Nov;234(3):351-64.
    Association of RHAMM with E2F1 promotes tumor cell extravasation by transcriptional upregulation of fibronectin.
    Meier C, Spitschak A, Abshagen K, Gupta S, Mor JM, Wolkenhauer O, Haier J, Vollmar B, Alla V, Pützer BM.